Multinational Clinical Trials in Oncology and Post-Trial Benefits for Host Countries: Where Do We Stand?
Mano, Max S.
Rosa, Daniela D.
Dal Lago, Lissandra
European Journal of Cancer 2006 November; 42(16): 2675-2677
Showing items related by title, author, creator and subject.
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study Sofaer, N.; Thiessen, C.; Goold, S.D.; Ballou, J.; Getz, K.A.; Koski, G.; Krueger, R.A.; Weissman, J.S. (2009-03)OBJECTIVES: To report the attitudes and opinions of subjects in US clinical trials about whether or not, and why, they should receive post-trial access (PTA) to the trial drug, care and information. DESIGN: Focus groups, ...
Post-Trial Access to Tested Interventions: The Views of IRB/REC Chair, Investigators, and Research Participants in a Multinational HIV/AIDS Study Pace, Christine; Grady, Christine; Wendler, David; Bebchuk, Judith D.; Tavel, Jorge A.; McNay, Laura A.; Forster, Heidi P.; Killen, Jack; Emanuel, Ezekiel J. (Espirit Group, 2006-09)